ParkinsonFranceV1, Main, Curation, bibRecord, 004A92

Apomorphine increases blood glucose concentrations in Parkinson's disease

Identifieur interne : 004A92 ( Main/Curation ); précédent : 004A91; suivant : 004A93

Apomorphine increases blood glucose concentrations in Parkinson's disease

Auteurs : F. Tison [France] ; N. Fouillet ; P. Henry

Source :

Clinical neuropharmacology [ 0362-5664 ] ; 1994.

RBID : Pascal:94-0257650

Descripteurs français

Pascal (Inist)
- Stimulant dopaminergique, Homme, Voie souscutanée, Glucide, Apomorphine, Glucose, Parkinson maladie.
Wicri :
- topic : Homme, Glucose.

English descriptors

KwdEn :
- Aged, Apomorphine (adverse effects), Apomorphine (therapeutic use), Blood Glucose (metabolism), Carbohydrate, Dopamine agonist, Glucose, Human, Humans, Levodopa (therapeutic use), Parkinson Disease (blood), Parkinson Disease (drug therapy), Parkinson Disease, Secondary (drug therapy), Parkinson disease, Subcutaneous administration.
MESH :
- chemical , adverse effects : Apomorphine.
- chemical , metabolism : Blood Glucose.
- chemical , therapeutic use : Apomorphine, Levodopa.
- blood : Parkinson Disease.
- drug therapy : Parkinson Disease, Parkinson Disease, Secondary.
- Aged, Humans.

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001983
to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :001668
to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001814
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005458
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001688
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001647
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001647
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001D28
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001D28
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001D28
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005272

Links to Exploration step

Pascal:94-0257650

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Apomorphine increases blood glucose concentrations in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hôp. Pellegrin, serv. neurologie</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">94-0257650</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 94-0257650 INIST</idno>
<idno type="RBID">Pascal:94-0257650</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001983</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001668</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001814</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001814</idno>
<idno type="wicri:doubleKey">0362-5664:1994:Tison F:apomorphine:increases:blood</idno>
<idno type="wicri:Area/Main/Merge">005458</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:8149364</idno>
<idno type="wicri:Area/PubMed/Corpus">001688</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001688</idno>
<idno type="wicri:Area/PubMed/Curation">001647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001647</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001647</idno>
<idno type="wicri:Area/Ncbi/Merge">001D28</idno>
<idno type="wicri:Area/Ncbi/Curation">001D28</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D28</idno>
<idno type="wicri:doubleKey">0362-5664:1994:Tison F:apomorphine:increases:blood</idno>
<idno type="wicri:Area/Main/Merge">005272</idno>
<idno type="wicri:Area/Main/Curation">004A92</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Apomorphine increases blood glucose concentrations in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hôp. Pellegrin, serv. neurologie</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Apomorphine (adverse effects)</term>
<term>Apomorphine (therapeutic use)</term>
<term>Blood Glucose (metabolism)</term>
<term>Carbohydrate</term>
<term>Dopamine agonist</term>
<term>Glucose</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
<term>Parkinson disease</term>
<term>Subcutaneous administration</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Apomorphine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Blood Glucose</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Apomorphine</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Stimulant dopaminergique</term>
<term>Homme</term>
<term>Voie souscutanée</term>
<term>Glucide</term>
<term>Apomorphine</term>
<term>Glucose</term>
<term>Parkinson maladie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Glucose</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<double idat="0362-5664:1994:Tison F:apomorphine:increases:blood"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Apomorphine increases blood glucose concentrations in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hôp. Pellegrin, serv. neurologie</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">94-0257650</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 94-0257650 INIST</idno>
<idno type="RBID">Pascal:94-0257650</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001983</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001668</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001814</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001814</idno>
<idno type="wicri:doubleKey">0362-5664:1994:Tison F:apomorphine:increases:blood</idno>
<idno type="wicri:Area/Main/Merge">005458</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Apomorphine increases blood glucose concentrations in Parkinson's disease</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F." last="Tison">F. Tison</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Hôp. Pellegrin, serv. neurologie</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N." last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P." last="Henry">P. Henry</name>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1994">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carbohydrate</term>
<term>Dopamine agonist</term>
<term>Glucose</term>
<term>Human</term>
<term>Parkinson disease</term>
<term>Subcutaneous administration</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Stimulant dopaminergique</term>
<term>Homme</term>
<term>Voie souscutanée</term>
<term>Glucide</term>
<term>Apomorphine</term>
<term>Glucose</term>
<term>Parkinson maladie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Glucose</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</INIST>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Apomorphine increases blood glucose concentrations in Parkinson's disease.</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F" last="Tison">F. Tison</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de Neurologie, Hôpital Pellegrin, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Hôpital Pellegrin, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N" last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P" last="Henry">P. Henry</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:8149364</idno>
<idno type="pmid">8149364</idno>
<idno type="wicri:Area/PubMed/Corpus">001688</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001688</idno>
<idno type="wicri:Area/PubMed/Curation">001647</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001647</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001647</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001647</idno>
<idno type="wicri:Area/Ncbi/Merge">001D28</idno>
<idno type="wicri:Area/Ncbi/Curation">001D28</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D28</idno>
<idno type="wicri:doubleKey">0362-5664:1994:Tison F:apomorphine:increases:blood</idno>
<idno type="wicri:Area/Main/Merge">005272</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Apomorphine increases blood glucose concentrations in Parkinson's disease.</title>
<author><name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F" last="Tison">F. Tison</name>
<affiliation wicri:level="3"><nlm:affiliation>Service de Neurologie, Hôpital Pellegrin, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Hôpital Pellegrin, Bordeaux</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Fouillet, N" sort="Fouillet, N" uniqKey="Fouillet N" first="N" last="Fouillet">N. Fouillet</name>
</author>
<author><name sortKey="Henry, P" sort="Henry, P" uniqKey="Henry P" first="P" last="Henry">P. Henry</name>
</author>
</analytic>
<series><title level="j">Clinical neuropharmacology</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Apomorphine (adverse effects)</term>
<term>Apomorphine (therapeutic use)</term>
<term>Blood Glucose (metabolism)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Parkinson Disease (blood)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Apomorphine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Blood Glucose</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Apomorphine</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Data from studies indicate that blood glucose levels may be influenced by stimulation of central D1 and D2 dopamine receptors. This is modulated by central dopamine receptor status. We studied apomorphine-induced increase in blood glucose levels in Parkinson's disease compared with those in Parkinsonian syndromes unresponsive to dopaminergic drugs. Results indicate that apomorphine-induced blood glucose level increases are significant only in Parkinson's disease. As in the animal, this could possibly be explained by central dopamine receptor status.</div>
</front>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A92 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004A92 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:94-0257650
   |texte=   Apomorphine increases blood glucose concentrations in Parkinson's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Apomorphine increases blood glucose concentrations in Parkinson's disease

Apomorphine increases blood glucose concentrations in Parkinson's disease

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri